For safety information please consult full
Summary of Product Characteristics specific to your region of practice. "Ropivacaine ReadyfusOR" may not be the approved medicinal product name in your country.
Please consult the Summary of Product Characteristics or Prescribing Information in your country to determine the approved medicinal product name.
* Please note that this site may include information regarding the product’s indications for use that are not consistent
with the approved marketing authorization, or marketing application, in all countries. The approved
indications and full summary of product of characteristics may vary from country to country. Please
refer to the nationally registered and approved Summary of Product Characteristics
or Prescribing Information for the indications, warnings, and dosage information for your country
of practice. If you require any further information regarding the approved use in the country in
which you practice, please contact your local representative.
Readyfusor and Ropivacaine Readyfusor are registered trademarks of BioQ Pharma, Inc.
2021 BioQ Pharma, Incorporated. All rights reserved.